Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
Sebastian Klapa, Specialist in Internal Medicine and Rheumatology at University of Lübeck, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press
ANCA-associated vasculitis (AAV) and the risk of mortality and cardiovascular morbidity.
In our recent paper, which has been accepted by Frontiers-Immunology, we focused on real-world data for mortality and a wide range of cardiovascular diseases in an enlarged cohort of over 20,000 AAV patients over a period of up to 20 years.
For the first time, we were able to compare over 5,000 MPA patients with GPA patients.
Key findings:
- Increased risk of death in AAV patients
- Elevated risk of all screened cardiovascular comorbidities, especially major adverse cardiac events (MACE)
- MPA patients presented an increased risk of MACE and peripheral arterial disease
Be aware of your AAV patients, even those in stable remission.
In addition to symptom-related diagnostics, we may need to regularly screen for cardiovascular diseases.
Many thanks to all the co-authors for their great contributions!”
Title: ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study
Authors: Sebastian Klapa, Katja Bieber, Artem Vorobyev, Marlene Ludwig, Gordon Vollert, Sabrina Arnold, Henning Olbrich, Henry Nording, Antje Müller, Khalaf Kridin, Jan Henrik Schirmer, Katja von Allwörden, Anja Staehle, Ralf Ludwig, Peter Lamprecht

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors